Thymus Regeneration Emerges as Key Strategy Against Age-Related Immune Decline

The thymus—a small gland above the heart that trains T-cells—shrinks dramatically with age, undermining our immune defenses and contributing to increased infection risk, poor vaccine responses, and cancer susceptibility in older adults. This comprehensive review in Ageing Research Reviews surveys the current state of thymus regeneration research, examining both the biological mechanisms driving thymic involution and emerging therapeutic strategies to reverse it. The authors explore multiple intervention approaches, from growth factors and cytokines to small molecules and cellular therapies, that have shown promise in animal models for restoring thymic function. Some strategies aim to rejuvenate the thymic epithelial cells that create the environment for T-cell development, while others target the stem cell populations that can regenerate thymic tissue. While most work remains preclinical, the review highlights this as a particularly promising avenue for combating immunosenescence—the age-related decline in immune function that affects nearly every aspect of health in later life. Success in thymus regeneration could potentially improve vaccine responses, reduce infection mortality, and enhance cancer immunotherapy effectiveness in older adults, making it a high-impact target for longevity interventions.